0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R1,000 - R2,500 (2)
  • R2,500 - R5,000 (1)
  • -
Status
Brand

Showing 1 - 3 of 3 matches in All Departments

Annals Meeting Reports (Paperback): D Braaten Annals Meeting Reports (Paperback)
D Braaten
R1,768 Discovery Miles 17 680 Ships in 10 - 15 working days

This Annals volume presents four scholarly meeting reports: (1) Application of combined omics platforms to accelerate biomedical discovery in diabesity; (2) Prioritizing health disparities in medical education to improve care; (3) The paradox of overnutrition in aging and cognition; and vitamin D: beyond bone. Diabesity has become a popular term to describe the specific form of diabetes that develops late in life and is associated with obesity. While there is a correlation between diabetes and obesity, the association is not universally predictive. Defining the metabolic characteristics of obesity that lead to diabetes, and how obese individuals who develop diabetes different from those who do not, are important goals. The use of large-scale omics analyses (e.g., metabolomic, proteomic, transcriptomic, and lipidomic) of diabetes and obesity may help to identify new targets to treat these conditions. This report discusses how various types of omics data can be integrated to shed light on the changes in metabolism that occur in obesity and diabetes. Despite yearly advances in life-saving and preventive medicine, as well as strategic approaches by governmental and social agencies and groups, significant disparities remain in health, health quality, and access to health care within the United States. The determinants of these disparities include baseline health status, race and ethnicity, culture, gender identity and expression, socioeconomic status, region or geography, sexual orientation, and age. In order to renew the commitment of the medical community to address health disparities, particularly at the medical school level, we must remind ourselves of the roles of doctors and medical schools as the gatekeepers and the value setters for medicine. Within those roles are responsibilities toward the social mission of working to eliminate health disparities. This effort will require partnerships with communities as well as with academic centers to actively develop and to implement diversity and inclusion strategies. Besides improving the diversity of trainees in the pipeline, access to health care can be improved, and awareness can be raised regarding population-based health inequalities. Populations of many countries are becoming increasingly overweight and obese, driven largely by excessive calorie intake and reduced physical activity; greater body mass is accompanied by epidemic levels of comorbid metabolic diseases. At the same time, individuals are living longer. The combination of aging and the increased prevalence of metabolic disease is associated with increases in aging-related comorbid diseases such as Alzheimer's disease, cerebrovascular dementia, and sarcopenia. Here, correlative and causal links between diseases of overnutrition and diseases of aging and cognition are explored. In recent years, vitamin D has been received increased attention due to the resurgence of vitamin D deficiency and rickets in developed countries and the identification of extraskeletal effects of vitamin D, suggesting unexpected benefits of vitamin D in health and disease, beyond bone health. The possibility of extraskeletal effects of vitamin D was first noted with the discovery of the vitamin D receptor (VDR) in tissues and cells that are not involved in maintaining mineral homeostasis and bone health, including skin, placenta, pancreas, breast, prostate and colon cancer cells, and activated T cells. However, the biological significance of the expression of the VDR in different tissues is not fully understood, and the role of vitamin D in extraskeletal health has been a matter of debate. This report summarizes recent research on the roles for vitamin D in cancer, immunity and autoimmune diseases, cardiovascular and respiratory health, pregnancy, obesity, erythropoiesis, diabetes, muscle function, and aging. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Blavatnik Awards for Young Scientists 2012 (Paperback): D Braaten Blavatnik Awards for Young Scientists 2012 (Paperback)
D Braaten
R2,974 Discovery Miles 29 740 Ships in 10 - 15 working days

This volume comprises contributions from faculty and postdoctoral finalists of the 2012 New York Academy of Science Blavatnik Awards for Young Scientists. The Awards recognize highly innovative, multidisciplinary accomplishments in the life sciences, physical sciences, mathematics, and engineering. Included in this volume are manuscripts of the individual finalists areas of research, which provide a glimpse of some of today s most compelling scholarly work. NOTE: Annals volumes are available for sale as individual books or as a journal. For more information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632 ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order ( www.nyas.org ). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.

Annals Meeting Reports (Paperback): D Braaten Annals Meeting Reports (Paperback)
D Braaten
R1,767 Discovery Miles 17 670 Ships in 10 - 15 working days

This Annals volume presents three scholarly meeting reports: (1) biomarkers in nutrition: new frontiers in research and application; (2) the new revolution in toxicology: The good, the bad, and the ugly; and (3) neuroprotection after cerebral ischemia. Nutritional biomarkers biochemical, functional, or clinical indices of nutrient intake, status, or functional effects are needed to support evidence-based clinical guidance and effective health programs and policies related to food, nutrition, and health. Such indices can reveal information about biological or physiological responses to dietary behavior or pathogenic processes, and can be used to monitor responses to therapeutic interventions and to provide information on interindividual differences in response to diet and nutrition. Many nutritional biomarkers are available; yet there has been no formal mechanism to establish consensus regarding the optimal biomarkers for particular nutrients and applications. In 2007, the United States National Academy of Sciences issued a report entitled Toxicity Testing in the 21st Century: A Vision and a Strategy. The report reviewed the state of the science and outlined a strategy for the future of toxicity testing. One of the more significant components of the vision established by the report was an emphasis on toxicity testing in human rather than animal systems. In the context of drug development, it is critical that the tools used to accomplish this strategy are maximally capable of evaluating human risk. Since 2007, many advances toward implementation of this vision have been achieved, particularly with regard to safety assessment of new chemical entities intended for pharmaceutical use. Cerebral ischemia, a focal or global insufficiency of blood flow to the brain, can arise through multiple mechanisms, including thrombosis and arterial hemorrhage. Ischemia is a major driver of stroke, one of the leading causes of morbidity and mortality worldwide. While the general etiology of cerebral ischemia and stroke has been known for some time, the conditions have only recently been considered treatable. This report describes current research in this field seeking to fully understand the pathomechanisms underlying stroke; to characterize the brain's intrinsic injury, survival, and repair mechanisms; to identify putative drug targets as well as cell-based therapies; and to optimize the delivery of therapeutic agents to the damaged cerebral tissue. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Advanced Credit Risk - Analysis And…
C Joseph Hardcover  (2)
R1,834 Discovery Miles 18 340
Bank Collections and Payment…
Benjamin Geva Hardcover R3,964 Discovery Miles 39 640
Reform and Regulation of Economic…
Haroun Rahimi Hardcover R3,801 Discovery Miles 38 010
An Introduction to Cryptocurrencies…
Nikos Daskalakis, Panagiotis Georgitseas Paperback R1,220 Discovery Miles 12 200
Diversity of Managerial Ideology
Check Teck Foo Hardcover R4,262 Discovery Miles 42 620
Going Infinite - The Rise And Fall Of A…
Michael Lewis Hardcover R698 Discovery Miles 6 980
Public-Private Collaborations for…
Veronica Vecchi, Francesca Casalini, … Hardcover R2,214 Discovery Miles 22 140
Banking, Risk and Crises in Europe…
Renata Karkowska, Zbigniew Korzeb, … Hardcover R3,928 Discovery Miles 39 280
Credit and Crisis from Marx to Minsky
Jan Toporowski Hardcover R2,506 Discovery Miles 25 060
Luxury, Fashion and the Early Modern…
Klas Nyberg, Hakan Jakobsson Paperback R1,292 Discovery Miles 12 920

 

Partners